autologous cytotoxic T lymphocytes activated by dendritic cells loaded non-small cell lung adenocarcinoma complex antigen (Shenzhen Immuclin Biomed)

N/A

Report date: 2025/01/26 19:35:51

Base Information

Drug Nameautologous cytotoxic T lymphocytes activated by dendritic cells loaded non-small cell lung adenocarcinoma complex antigen (Shenzhen Immuclin Biomed)

Drug Alias NameACTLs activated by dendritic cells loaded non-small cell lung adenocarcinoma complex antigen (Shenzhen Immuclin Biomed)

ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > T-lymphocyte cell therapy

Mechanisms of ActionImmunostimulantsT lymphocytes stimulants

TargetsUpdating

Therapy Area/IndicationsCarcinoma, Non-Small-Cell Lung

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryMainland China

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaPreclinical

Originator CompaniesImmuclin Biomed Inc

China Registration ClassN/A

Develop Information

Active CompaniesImmuclin Biomed Inc

Inactive CompaniesN/A

Active IndicationsCarcinoma, Non-Small-Cell Lung

Inactive IndicationsN/A

Other Information

ATC CodeN/A